NCT02986074 - CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions

Chronic Pain

Interventions

DEVICE

Paresthesia mapping lead evaluation first

Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using paresthesia mapping in the first part of the SCS trial and using the lead implanted using anatomical midline placement in the second part of the SCS trial

DEVICE

Anatomical midline lead evaluation first

Subjects will evaluate the clinical efficacy of stimulation delivered using the lead implanted using anatomical midline in the first part of the SCS trial and using the lead implanted using paresthesia mapping placement in the second part of the SCS trial

Trial Locations (2)

LS14 6UH

Seacroft Hospital, Leeds

SE1 7EH

St. Thomas Hospital, London